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Abstract
Although numerous studies on heroin-assisted treatment (HAT) have been published in leading international journals, little
attention has been given to HAT’s clients, their stories, and what constitutes the most influential factor in the treatment
process. The present study investigates the role of HAT in transforming the lives of injection drug users (IDUs) in
Vancouver, Canada. This study is qualitative focusing on 16 in-depth interviews with patients from the randomized trials of
HAT. Interviews were transcribed verbatim and analyzed thematically using NVivo 10 software. The findings revealed a
positive change in many respects: the randomized trials reduce criminal activity, sex work, and illicit drug use. In addition,
the trials improved the health and social functioning of its clients, with some participants acquiring work or volunteer
positions. Many of the participants have been able to reconnect with their family members, which was not possible before
the program. Furthermore, the relationship between the staff and patients at the project appears to have transformed the
behavior of participants. Attending HAT in Vancouver has been particularly effective in creating a unique microenviron-
ment where IDUs who have attended HAT have been able to form a collective identity advocating for their rights. The
result of this research points to the need for continuation of the project beyond the current study, leading toward a
permanent program.
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The Downtown Eastside (DTES) of Vancouver,
Canada, was the center of North America’s open
illicit drug scene for decades (Jozaghi, 2012, 2014;
Kerr, MacPherson, & Wood, 2008). During the mid-
1990s, the area’s problems escalated when several
factors, such as an increase in the availability of
powder cocaine, lack of social housing, and de-
institutionalization resulted in a multiple epidemic of
injection drug use, HIV, and drug overdose deaths
(Jozaghi, 2012). What differentiated Vancouver from
other North American cities was the magnitude of
the outbreak; for example, between 1990 and 2000
HIV prevalence rate among injection drug users
(IDUs) rose from 4% to up to 40% (O’Shaughnessy,
Hogg, Strathdee, & Montaner, 2012). At the same
time, a growing overdose epidemic was taking place
within the IDU population in Vancouver, with 1200
deaths occurring between 1992 and 2000 (Kerr
et al., 2008).
According to Kerr, Small, Hyshka, Maher, and
Shannon (2013), Vancouver ‘‘has long been home to
dual epidemics of heroin injection and heroin related
overdose’’ (p. 108). In fact, there have been numer-
ous public warnings regarding heroin-related deaths
in Vancouver (Kerr et al., 2013). In addition to over-
dose deaths, there are numerous costs to the health
care, criminal justice, and welfare systems when
dealing with the numerous challenges that opioid
and heroin users pose for the government (Gartry,
Oviedo-Joekes, Laliberte, & Schechter, 2009). A
recent Auditor General’s report estimated illicit
drug use to cost Canadian tax payers an estimated
$5 billion annually (Miller et al., 2004). According
to the Auditor General’s report, the societal cost of
untreated heroin addiction exceeds $45,000 per
person per year (Status Report, 2008). Since the
1960s in Canada, methadone maintenance therapy
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(page number not for citation purpose)(MMT) has been the main substitute for heroin and
opioid addiction (Dole & Nyswander, 1965).
MMT has been shown to be effective in decreas-
ing the incidence of illicit opioid use and cravings;
additionally, in some cases, MMT may lead to absti-
nence (Gartry et al., 2009). However, several factors
have suggested the inefficiency of MMT for some
users. For example, ‘‘inadequate methadone doses,
user fees, punitive urine testing, and a lack of high
associated with MMT’’ have all been cited (Gartry
et al., 2009, p. 2). Additionally, MMT is not effec-
tive in all cases; between 15 and 25% of patients do
not respond to MMT, especially among long-term,
high-risk patients (van den Brink et al., 2003; Mino,
Page, Dumont, & Broers, 1998).
In response to the growing number of addicts
who do not respond to traditional MMT programs,
numerous European countries have started experi-
menting with pharmaceutical heroin. Since 1926,
addiction treatment in the United Kingdom has
included heroin prescription (Gartry et al., 2009).
In the Netherlands and Switzerland, heroin-assisted
treatment (HAT) clinics have been in operation since
the 1990s, and Germany is in the process of creating
a centralized system for diamorphine (Gartry et al.,
2009). The scientific evaluation of HAT has been
very positive in European countries (Gartry et al.,
2009).
Canada has also taken notice of the success of the
HAT program in Europe. In September 1998, the
first North American Opiate Medication Initiative
(NAOMI) working group was formed (Gartry et al.,
2009). Recruitment in Montreal and Vancouver
began in March 2005 and ended in April 2007
(Gartry et al., 2009). The 12-month program ended
in June 2008, with 251 of the most marginalized and
chronic opiate users entering the program (Gartry
et al., 2009). Evaluation of the NAOMI, according
to numerous peer-reviewed studies, has been posi-
tive (Bohdan et al., 2012; Nosyk et al., 2010; Kahan,
Srivastava, & Conway, 2011).
In the interim, another set of trials, the Study to
Assess Long-term Opioid Medication Effective-
ness (SALOME), has begun to test whether people
affected by chronic opioid addiction, who are not im-
proving sufficiently from other treatments, will benefit
from hydromorphone (a licensed medication), and
whether hydromorphone is as effective in treating
addiction as diacetylmorphine (Mickleburgh, 2011;
Oviedo-Joekes et al., 2009). SALOME began active
recruitment in December 2011 (Boyd, 2012). After
1 year of participating in the program, participants
were encouraged to take part in conventional treat-
ment, such as MMT and detox, during a period
of transition (Boyd, 2012). The current study seeks
to determine the transformative role of HAT in the
lives of IDUs. Specifically, this study will account
for (1) experience prior to the SALOME trial; (2)
injection behavior of clients before enrolling in the
programs; (3) injection behavior post-enrollment
into SALOME; (4) health status before and after
the enrollment; (5) activism in the community; and
(6) an open discussion regarding how the program
was successful. This is the first qualitative study of
SALOME. It is believed that participants’ accounts
generated by qualitative narratives create opportu-
nities for discovering a rich detailed description.
This study will show the behavior of participants in
the SALOME project in the DTES to be shaped by a
complex interplay of individual and social factors,
which are not amenable to quantitative measure-
ments (Rhodes & Treloar, 2008).
Methods
Participants
This study was approved by Simon Fraser University’s
Research Ethics Board (study No.: 2013s0279).
Beginning in May 2013, participants living in the
DTES, and those who in the previous week had
attended SALOME, were recruited to participate in
the study. Participants were eligible for the study
if they were 19 years or older and provided oral
consent. To protect confidentiality, all identifying
information was removed from interview transcripts
and all names used in this paper are pseudonyms.
The study was facilitated through recruitment of
participants through purposive sampling via key
informants (Jozaghi & Andresen, 2013; Jozaghi,
2013). The researcher and the key informants had
a pre-existing relationship that was established dur-
ing the researcher’s previous volunteer work in the
DTES.
1 The first key informant was one of the co-
founders of NAOMI Patients Association (NPA).
The researcher had met her through the Vancouver
Area Network of Drug Users (VANDU). The second
key informant was a volunteer at Washington’s Needle
Depot in the DTES, where the researcher also
volunteered for 2 years. To protect the confidenti-
ality of participants, this research only reported the
demographic characteristics of the participants in a
quantitative manner (Table I).
Participants were told by key informants that the
interviewer was a doctoral student. None of those
who were invited to participate refused. In fact, the
referral by the key informants allowed the par-
ticipants to feel comfortable and open up more
easily about their experiences. Sixteen purposefully
chosen IDUs were found to be eligible for this study.
When the interview took place, six participants
had been in the program for more than 6 months,
E. Jozaghi
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4 months, and the remainder of the participants
had been in the program for 2 months.
Procedure
Open-ended, semi-structured interviews were con-
ducted through the use of an interview guide. Using
Dragon Naturally Speaking software, all the tran-
scripts were transcribed verbatim. Apart from a few
key questions, participants were encouraged to dis-
cuss the issues as they saw fit. Each interview took on
a story of its own. All participants indicated genuine
interest in the interview by using individual examples
and had unique stories to shape the direction of the
interview. As suggested by Berg (2009), deviations
were explored in all the interviews, because topics
arose from natural conversation.
A digital voice recorder (Olympus WS-700M) and
a small notebook were used to allow the researcher
to jot down key words or phrases during the inter-
view. This strategy allowed the researcher to pay
attention to the participants and take occasional
notes to retain the flow of the interview. Also, the
researcher took time to record field notes after each
interview, including impressions of the interview,
questions to ask in future interviews, and interesting
themes to consider during the analysis. This strategy
allowed for the recording of rich details about each
interview.
Data analysis
After reviewing the qualitative data (notes and
transcripts), NVivo 10 software was used for the-
matic analysis. Before importing the data in NVivo
10, interviews were listened to several times.
By relying on NVivo 10, themes were coded as
nodes. The first stage involved in this process was
open coding. During this stage, through deductive
and general observation using a word frequency
query, ‘‘free’’ nodes were created which resulted in
more specific categories. Free nodes were created
after key words*identified during the world fre-
quency query*were searched in the transcript. The
researcher grouped information into smaller sections
Table I. Characteristics of the sample of SALOME in Vancouver.
n %
Age
20 30 1 6.25
31 40 1 6.25
41 50 9 56.25
51 61 5 31.25
Gender
Male 9 56.25
Female 7 43.75
Ethnicity
Caucasian 12 75.0
First Nation 4 25.0
Sexual orientation
Heterosexual 15 93.75
Homosexual 1 6.25
Number of injection per day (X)
X 0 (oral) 5 31.25
2 Bx53 9 56.25
x 3 2 12.5
Years of injection (Y)
Y510 2 12.5
10 BY520 4 25.0
Y 20 10 62.5
Medical condition
Nil 3 18.75
Hepatitis B 1 6.25
HCV 10 62.5
Mental illness 1 6.25
Mental illness and HCV 1 6.25
Dosage per day in mL (m)
10 Bm520 1 6.25
20 Bm5200 2 12.5
20 Bm5500 5 31.25
500 Bm51000 8 50.0
High school education
Yes 6 37.5
No 10 62.5
Sex trade in the last 6 months
Yes 1 6.25
No 15 93.75
Money/drugs for sex in the last 6 months
Yes 3 18.75
No 13 81.25
Relationship status
Single/divorced 14 87.5
Married/common law 2 12.5
Months in the program (a)
0 Ba52 2 12.5
2 Ba56 3 18.75
a 6 11 68.75
Principal dwelling place
Private residence or other’s house 15 93.75
Street/shelter 1 6.25
Criminal record
Yes 15 100.0
No 0 0.0
Unemployed
Yes 15 93.75
No 1 6.25
Table I (Continued)
n %
Years of residing in the DTES (Z)
2 5Z515 11 68.75
15 BZ525 4 25.0
Z 25 1 6.25
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for each.
For example, 19 free nodes were identified and
labeled as the following: (1) relationships; (2) nega-
tive effects; (3) beginning; (4) oral; (5) health; (6)
methadone; (7) NAOMI/SALOME history; (8)
changes in behavior; (9) dosage; (10) overdose; (11)
services; (12) transition; (13) normal life; (14) life
prior to HAT; (15) change; (16) activism; (17) crime;
and (18) frustration.
Through an inductive search, a ‘‘tree’’ node was
created for general themes, in which the sections
were grouped into common categories. This process
was performed iteratively until all interview tran-
scripts had been accounted for, and all new or
developing themes had reached a saturation point.
To avoid overrepresentation of themes, the most
dominant themes were identified through the orga-
nization and analysis of the data.
In addition, the coding was conducted via color
highlighters. Analyzing the data via highlighters was
a rather natural process and resembled ‘‘the spiral-
ling research approach’’ (Berg, 2009, p. 26). As I
was transcribing the interviews and later analyzing
them via highlighters, it did not take long to realize
possible themes that were emerging and what these
themes may mean in terms of the existing literature.
Further, during the writing process I was still en-
gaged in the process of coding, and analysis, as I
was thinking of new themes, reframing themes, and
revisiting the tapes and transcripts for elaboration or
conformation.
Findings
To illustrate the central themes that emerged in the
cross-case analysis, excerpts from the qualitative
interviews are presented below. Dominant themes
included the following: activism, health, social te-
nure, and crime. Although the systematic analysis
with NVivo 10 software confirmed a broad overlap
across thematic areas among study participants, data
were analyzed from each participant independently.
Activism
The SALOME project could not be comprehended
without considering the NAOMI project’s influence
on many participants after the program ended.
Although participants praise the NAOMI project
for their efforts to provide heroin prescription in the
DTES, they also remain critical of the program for
its lack of exit strategy. For example, according to
Lila:
Once NAOMI study ended I was devastated
.... The ethics behind what they did is wrong
...out of the 97 of us that were on the needle
side 13 people died ... that’s like 15% of
people died because they couldn’t cope with a
life outside anymore ... people were just de-
vastated they could not cope with the hustling
again with selling their bodies or committing
crime. After NAOMI ended a lot of girls
turned into the street to support their habit.
And so many guys started the hustling again
and turned into the life of crime.
According to Boyd and NAOMI Patients Asso-
ciation (2013), the NAOMI project’s conclusion
was questionable on many issues, including its
failure to provide a permanent program, the absence
of an exit strategy, and lack of informed consent.
Boyd and NAOMI Patients Association (2013) also
point to the Helsinki Declaration on international
ethical standards where ‘‘at the conclusion of a
study, every patient ... should be assured access
to the best ... methods identified by the study’’
(p. 7). According to Lila, the failure of the NAOMI
project to ensure an exit strategy and the approval
of a similar study to be conducted in the DTES
ignited the creation of an advocacy group called
the NPA:
The people who were on NAOMI decided to
form a group and we started talking and we
heard SALOME was coming in place and we
were not going to stop and let them do the
same thing that they did to us. This time it’s
going to be 360 people who were going to be
on this program. And that’s why we found the
NPA. We decided to recruit people who were
known to us and bring them to the meetings
at VANDU. They wanted to make sure that
SALOME gets the proper procedure and so
that they’re not going to screw us all over again.
We learned over the years that peer groups
work.
Currently, members of NPA have weekly meetings
at the VANDU, where they discuss the issues facing
the participants at SALOME (Boyd & NAOMI
Patients Association, 2013). To achieve their goals,
members of NPA have been politically active in their
community. As Lila describes:
And as part of [NPA] we went to rallies ...we
went to Providence Health, we went to the
Vancouver Coastal Health meetings so they
could hear our voice: not just academics, but
also people like us, junkies on the street that are
affected by these programs every day. And it
E. Jozaghi
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4 to 5 of us. But within six months we were
able to get hold of 40 people who were part of
the project. The group got bigger by that time.
...We have gone through different conferences
talking about our cause.
Some members of NPA are not only dedicated to
and focused on supporting their members, but they
are also involved in advocacy work and political
empowerment in the DTES. The NPA, according to
Boyd and NAOMI Patients Association (2013), is
also involved in education of its members and the
general public. Therefore, after advocating for their
rights since January 2011, NPA has recently been
successful in forcing the government to extend the
program for those who will remain on the oral use of
hydromorphone.
Increased health
All 16 participants indicated that their health and
well-being has improved drastically since enrolling in
SALOME. Many of the participants have been able
to improve their nutrition, and to reduce their stress
and risky behavior, such as sex work. For some of the
participants such as Monique, SALOME has even
allowed her to look for a job:
Life is less stressful, I don’t have to worry about
my next fix I don’t have to worry about getting
sick. It has enabled me to do other things like
look for a job or volunteer work in the Down-
town Eastside. Before I had to go, get ready to
go to work every night on the Street and I don’t
have to do that anymore.
Miller et al.’s (2004) study also demonstrated
that a medical heroin prescription program has the
potential to moderately increase employment rates
for these DTES residents. For some of the partici-
pants such as Joe, the program has helped them to
recover from long term illness and the struggle with
addiction:
My health was really bad ... I was always in
pain and constantly in and out of hospital. And
when you’re down and shit like that and you’re
sick and in pain all the time, it’s a shitty way to
live your life. This was the God work for me to
get on the program. Don’t necessarily get high
on the program but get well, to manage my
pain now way better than before. Now I have a
lot more energy before I was sick all the time.
All of a sudden I have that energy, I have the
drive, I have that motivation.
Previous studies have also demonstrated that heroin
prescription programs are able to reduce hospital
stay times and the number of emergency room visits
(Miller et al., 2004; van den Brink et al., 2003).
The study by Nosyk et al. (2010) also showed that
the motivational status of patients was instrumental
in creating a more favorable response to treatment.
Many of the participants indicated that because of
SALOME, they have been able to change their
life around and reduce daily stress. This is particu-
larly important for participants such as Nicole who
suffered from a mental illness:
SALOME gave my dignity back. Didn’t make
me feel like ...I was a loser ....N o wIh a v ea
better relationship with my adult children. All
of a sudden when you realize you’re an addict
and you hide it, and you finally get the chance
to tell somebody. And this is what SALOME
has done for me. And they allowed me and
encouraged me to tell my story. It’s hard to get
used to it at first that your opinion counts. Give
me a chance to do something about my life and
finally change my life for the better. I do think
if it wasn’t for SALOME at this point in my life
I would be very depressed. I used to suffer from
depression.
According to Small and Drucker (2006), prescrip-
tion heroin programs reach a refractory group of
addicts who, through their interaction with staff and
doctors in the clinics, are able to improve their health
status. Furthermore, as stated above, heroin pre-
scription trials enable and empower their clients to
contact their families (Small & Drucker, 2006).
Social tenure
For all participants, the relationships they have been
able to establish with the social workers, nurses,
and doctors at SALOME have enabled them to
move beyond their addiction needs. One participant,
Arthur, received much needed help for his hepatitis
C (HCV) condition:
They helped me to get full dietary for my Hep
C. With the help of SALOME I had a lot of
dental work done .... And they helped me ...
to get my life get on track. SALOME helps
me in regards to my use, and addiction. I was
fixing about eight points a day
2 where today
I only fix one point a day. I feel like that I
accomplished so much since I’ve been on this
program. They are decreasing my dose right
now where I’m hoping by the end of it, I will be
able to go on detox and quit using drugs.
The role of randomized heroin trials
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study’s findings that heroin prescription programs
lead to reduced drug use. Furthermore, European
studies, including ones from Switzerland, Germany,
Spain, and the Netherlands, have shown that opiate
addicts prescribed heroin under supervision have
successfully reduced their drug use (Gartry et al.,
2009). Many of the participants indicate that their
life has been transformed for the better due to the
kind relationships the staff has fostered with their
clients. For instance, according to Ashley:
SALOME people help us to get housing, we got
evicted from our place where we lived and they
went to arbitration with us. They did our taxes.
They even came to the Ministry so I could see
my son. And if I go on two different appoint-
ments they stay with me and calm me down
because I have an anxiety disorder and talked
with me because of my anxiety problem ....
And I come from a very disadvantaged family,
where there was a lot of incest in my family, and
the person that I felt comfortable talking about
my experience was at SALOME with the
counselors and the doctor there and they were
very supportive of me.
Oviedo-Joekes et al.’s (2008) study also suggests that
the NAOMI cohort comprised a higher proportion
of marginalized populations, such as those resid-
ing in unstable housing. The relationship building
efforts of the staff could be one of the influential
factors contributing to the improved social function-
ing of participants. Additionally, nurses at the facility
have been successful in reducing the possibility of
drug overdose death with participants at the facility.
For example, according to Monica:
I was Narcaned for the first time at SALOME,
and if I wasn’t at SALOME, I’d be dead
because I usually fix alone .... Also my ex-
husband overdosed numerous times and they
saved his life too .... They also gave me training
to use Narcan. The pharmacist at SALOME
actually gave us a speech and told us how to
use it. People drop in the Downtown Eastside,
people pretend that they’re helping them, but
they are robbing them instead.
Injecting outside of SALOME carries association
of fear, overdose, and death, which reinforce the
security and safety that participants have come to
associate with the facility. In fact, all the participants
who have used SALOME have seen an overdose
or have experienced an overdose at SALOME,
and all of them agree that the quick responses of
nurses to an overdose situation has reduced the
possibility of overdose deaths. Furthermore, the
relationship between patients, nurses, social workers,
and doctors at the facility has facilitated harm
reduction education.
Diminished criminality
The most common theme across the analysis was
related to illicit behavior of participants prior to en-
rolling into SALOME program. As shown in Table I,
all the participants had some sort of reported cri-
minal record. For female participants, such activities
usually involved sex work and drug dealing. For
male participants, they usually involved breaking-
and-entering, shoplifting, drug dealing, and robbery.
According to Michael, criminal activity prior to
SALOME is tied to the vicious cycle of addiction or
as he puts it, ‘‘the dope sickness’’
3:
My main concern every day, all day was
making sure I was going to be able to get some
kind of opiates right .... So I was constantly
looking to make the money for my dope, and it
just consumes you. Doesn’t matter about any-
thing else, the only biggest concern is to get the
money so you wouldn’t get dope sick. My life
was a fucking mess because the only thing I
cared about was dope sickness. It was all about
getting that money. It wouldn’t matter, I would
stay awake for days so I would be able to get the
money. As soon as you pass that point that
you’re sick, then you’re scored .... Sometimes
it’s friends; other times, desperation kicks in.
And when you’re desperate, anything goes.
The Vancouver Board of Trade estimated in 2005
that property crime was costing the city’s taxpayers
$125 million annually (Park, 2009). The majority of
property crimes, according to the Vancouver Police
Department, are committed by addicts who can
require $100 or more daily for purchasing drugs
(O’Conner, 2009). The DTES of Vancouver is the
crime’s ‘‘ground zero’’ where in 2008 the area ac-
counted for 16% of sexual assaults, 22% of rob-
beries, and 34.5% of serious assaults (O’Conner,
2009). However, SALOME altered the criminogenic
behavior of participants such as Rob:
I used to do a lot of debt collection for a lot of
dealers down here*that was my job before
SALOME. But nowmyjob is freelance reporter
in the Downtown Eastside community. I was a
very violent person but now I have taken a
different route and I have been able to manage
my anger and work through my problems. So
SALOME has allowed me to take a step back
and say to myself: ‘‘There is something that
E. Jozaghi
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able to change my life, because SALOME has
provided the stability and security where I don’t
have to hustle, hurt people and break into the
cars to support my habit.
According to DeBeck et al.’s (2007) research, the
costs associated with illicit drugs are ‘‘compelling
IDUs, specifically those possessing markers of higher
intensity addiction, to engage in prohibited income
generating activities’’ (p. 50). However, as suggested
by Rob above, once participants are enrolled in the
SALOME program, they no longer feel the urge to
commit criminal activity to support their habit.
Some of the participants, such as Jack, have been
able to not only reduce their illicit behavior, but turn
their lives around:
I am not as aggressive as before because of
SALOME. My personality is much more bear-
ing. I don’t get hyper. I don’t have to get up
early to go hustle. I am more calm and reserved.
And because I don’t have to be rushed to make
that extra buck, it gives you hope that people
are not treating you as a disease and a piece of
shit ... I didn’t even like myself before the
SALOME. But now I can look into a mirror
and see a totally changed person. I like myself
now. Talking to doctors and social workers at
SALOME had affected me the most because
they are not only giving you the drug, they also
talk to you, they treat you like a human being
.... They help you with better housing ...[and]
how to get healthy, and they are there for you if
you just want to talk to someone.
Miller et al. (2004) estimate that medically pre-
scribed heroin programs have the potential to
decrease criminal activity, hospital, and emergency
costs by $9650, a 63% reduction. According to Dr.
Schechter, although the SALOME program may
cost $7500 per addict, this is a bargain compared to
the estimated $50,000 each untreated addict costs
the health care system (Skelton, 2008).
Discussion and conclusions
This paper set out to investigate whether SALOME
was successful in improving the lives of its parti-
cipants. Specifically, this study was interested in
accounting for (1) experience prior to the SALOME
trial; (2) injection behavior of clients before enroll-
ing in the programs; (3) injection behavior post-
enrollment into SALOME; (4) health status before
and after the enrollment; (5) activism in the com-
munity; and (6) an open discussion regarding how
the program was successful. The findings revealed a
reported positive change in many respects: SALOME
reduces criminal activity, sex work, and illicit drug
use. In addition, SALOME has improved the health
and social functioning of its clients, with some par-
ticipants acquiring work or volunteer positions.
Many of the participants have reconnected with their
family members, an unlikely feat before SALOME.
Furthermore, the relationship between the staff
and patients at SALOME has helped to transform
the behavior of participants. The staff has been able
to establish trust amongst the participants that has
ultimately helped participants get much needed
medical help for their undiagnosed medical condi-
tions such as mental illness or endocarditis. The close
bond and the relationship that exists between the
staff and patients at SALOME has increased nursing,
counseling care, and harm reduction education. The
social workers at SALOME have also been able to
improve the housing and financial situations of parti-
cipants through social housing and income assis-
tance. The findings of this study also suggest that in
order for the benefits to continue, the program needs
to become permanent, in order to avoid the same
consequences as the NAOMI project.
The most prominent finding of this study has
been the identification of social activism by IDUs
who have attended the randomized trials. According
to Capitanio and Herek (1999), drug users have
received particularly harsh condemnation over the
past century through labeling; IDUs, and drug users
in general, are viewed as ‘‘dregs of society who steal
to support their habit and pollute mainstream
society with their chaotic behavior and drug related
illness’’ (Hippel & Brener, 2012, p. 1030). Further,
Harris and Fiske (2006) claim that IDUs are often
dehumanized by others in society. These repressive
measures and labeling of drug users can be under-
stood through social constructionism. From a social
constructionist perspective, meaning is assigned to
an act or a behavior through a process of labeling
by groups who seek to elicit a particular response.
That is, something is defined as a social problem
not based on the inherent nature of the behavior,
but based on social responses to the behavior often
instigated by the claim making of a particular group.
According to Derlega and Barbee (1999), once
IDUs and drug users have been judged as socially
illegitimate, they are excluded or ignored altogether.
However, members of SALOME trials have been
able to move beyond the demonizing rhetoric they
endured as a consequence of the war on drugs. They
have not only been able to change the dynamic of
power relation that manifests in disproportionate
suffering, but they have been able to reduce the
misery that many IDUs experienced after the
NAOMI project ended. Now they have a political
The role of randomized heroin trials
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(page number not for citation purpose)voice through the NPA where they are able to discuss
their weekly encounters with nurses, doctors, and
social workers and raise their collective voice if they
see any unfairness.
During their weekly meetings they are able to
educate themselves and others about the benefits of
HATs. They have been able to raise awareness about
their cause through public demonstrations, writing
poems, and inviting media to their meetings. Despite
the challenges in the future, their collective identity
will help them to push the boundaries and continu-
ously strive to represent the concerns of SALOME
patients. For example, with the help of the NPA
and the Pivot Legal Society, some of the IDUs
have filed a lawsuit against the Canadian federal
government’s decision to stop doctors prescribing
heroin to patients who have transitioned into oral
diacetylmorphine (Woo, 2013).
Despite the noted findings above, the current
study has several limitations that should be acknow-
ledged. First, although this study reports many com-
mentaries related to experiences, perspectives, and
values of participants at SALOME, because of
access and the time spent in the field, triangulation
was limited. The researcher would have preferred
to supplement many of the interviews with more
observations, especially regarding interactions be-
tween the participants and staff within the SALOME
location.
Second, although purposive sampling has shown
to be instrumental, additional participants would
ultimately be required. Consequently, all the partici-
pants referred to the researcher had similar view-
points regarding the role of SALOME. Finally,
despite this study’s attempts to reduce the social
desirability effect*byreminding the participants that
there are no right or wrong answers and avoiding
leading questions*its influence on participants was
unavoidable. Consequently, some positive responses
in regard to SALOME can be attributed to the social
desirability effect. Moreover, the way the interviewer
asked the questions, directed the conversation, closed
the conversation, determined what constituted a
correct or complete answer, and paid the partici-
pants, may have influenced participants’ responses
(Jozaghi, 2012). In addition, manyof the participants
were recruited from aclinical trialwhere considerable
resources are put in and the ‘‘enthusiasm’’ factor may
well have influenced the positive treatment outcome.
Some studies have gone as far as suggesting that up
to 14% of the difference between responses can be
attributed to enthusiasm and the social desirability
effect (Heerwing & McCabe, 2009).
In summary, the current study was meant to gen-
erate discussion around the controversial SALOME
experiment in Vancouver which is still ongoing. The
current study demonstrated some societal, health,
and criminal justice benefits that have derived from
the SALOME experiment. Furthermore, the present
study provided a snapshot of benefits for those
participants who not only have engaged in long
term illicit drug use, but also have not benefited from
effective methadone therapy. However, the most sig-
nificant finding of this study lies in the activism
of IDUs, who have organized themselves to advocate
for their rights. Despite the challenges in the future,
their collective identity will help them to push the
boundaries and continuously strive to represent the
concerns of SALOME patients. It is our hope that
continuing qualitative research will provide some of
the critical information needed for government and
health policy makers to make informed decisions,
thereby reducing the harms and costs of opiate
addiction in our society.
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Notes
1. The interviewer volunteered in the Washington’s Needle Depot
in the DTES for 2 years.
2. This refers to 0.8 g of heroin, or eight doses of 0.1 g.
3. ‘‘Dope sickness’’ refers to opiate withdrawal symptoms.
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